Sean Ekins graduated from the University of Aberdeen; receiving his M.Sc., Ph.D. and D.Sc. He is Senior Consultant for Collaborations in Chemistry, and VP Science at Collaborative Drug Discovery Inc. In addition he is Adjunct Professor, Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill; Adjunct Associate Professor, School of Pharmacy Department of Pharmaceutical Sciences, University of Maryland; Adjunct Professor in the Department of Pharmacology at University of Medicine and Dentistry of New Jersey - Robert Wood Johnson Medical School, Piscataway, He has been a postdoctoral fellow at Lilly Research Laboratories, senior scientist at Pfizer and Lilly Research Laboratories; Associate Director of Computational Drug Discovery at Concurrent Pharmaceuticals, Inc and Vice President of Computational Biology at GeneGo.
Sean has authored or co-authored ~200 peer reviewed papers and book chapters on computational ADME and drug discovery as well as edited/ co-edited four books. He is the Reviews Editor for Pharmaceutical Research, Associate Editor of the Journal of Pharmacological and Toxicological Methods, is on the Editorial Board Drug Discovery Today and Mutation Research Reviews. He currently serves on the board of directors of the Pistoia Alliance. Sean co-developed the mobile apps ODDT (Open Drug Discovery Teams) and TBmobile and has been awarded 6 NIH grants as Principal Investigator. He is currently actively engaged in drug discovery for tuberculosis, malaria and rare diseases.